REMODULIN OFFERS SUPPORT TO
HELP YOU WORK TOWARD YOUR GOALS
If you’re thinking about taking Remodulin, or even if you’re already taking it, United Therapeutics has created a program just for you. When you sign up, you’ll receive a series of emails designed to deliver important information and tips, wherever you are on your treatment journey.
You will also receive the Remodulin Patient Journal in the mail. It includes helpful tips and a place to record important information to help you work toward the treatment goals you and your healthcare provider determine are appropriate.
Office Visit Discussion Guide
Want to get more from your next appointment? This guide may help.
An easy way to familiarize yourself with some of the common pulmonary arterial hypertension (PAH) terms you may hear.
Learn about financial assistance resources and programs.
Hear Patient Stories
Visit the In Stride YouTube channel to learn more about Remodulin and hear patients talk about their experiences with treatment.
United Therapeutics created the United by PAH Support Program to assist you in your PAH journey. Together, we can take a united approach against PAH. Whether you need to find more information about PAH, access support and resources, connect with other patients, or learn more about your treatment options, we're here to help.
PEER Network. Connect with a volunteer patient or caregiver mentor who has personal experience with Remodulin and can offer emotional support. Whether you're considering or already taking Remodulin, join the PEER Network and take advantage of this program. Call 1-866-505-7337 for more information.
The PHA (Pulmonary Hypertension Association) provides hope for the PAH community through support, education, advocacy, and awareness. It includes patient support groups and offers information on PAH specialists in your area.
PHAware creates global pulmonary hypertension awareness through engagement and innovation to forge a new course to a cure.
The NHLBI (National Heart, Lung, and Blood Institute) provides valuable information about heart, vascular, and lung diseases. It also has information on clinical trials and research opportunities.
The AHA (American Heart Association) funds cutting-edge research, conducts lifesaving public and professional educational programs, and advocates for public health.
Learn about financial assistance for Remodulin
Remodulin® (treprostinil) Injection
What is Remodulin?
Remodulin is a prescription medication used to treat adults with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. Remodulin can reduce symptoms associated with exercise. Remodulin was studied mainly in patients with NYHA Functional Class II-IV symptoms. It is not known if Remodulin is safe and effective in children.
In people with PAH who need to switch from epoprostenol, Remodulin is approved to slow the worsening of symptoms.
Important Safety Information for Remodulin
Before you take Remodulin, tell your healthcare provider if you:
- Have other medical conditions or take other medicines that may affect your use of Remodulin by increasing the risk of side effects or decreasing the drug’s effectiveness.
- Have liver or kidney problems. Your Remodulin dose may need to be adjusted if you have liver problems.
- Have low blood pressure or bleeding problems.
- Are taking gemfibrozil (for high cholesterol), rifampin (for infection) or other drugs that affect liver enzymes. Your doctor may need to adjust your Remodulin dosage.
- Are pregnant, breastfeeding, or planning to become pregnant. It is not known if Remodulin will harm your unborn baby or if Remodulin passes into your breast milk.
What are the serious side effects of Remodulin?
- Continuous intravenous (IV) infusions of Remodulin delivered using an external infusion pump, with a tube placed in a central vein within the chest, are associated with the risk of blood stream infections and sepsis, which may be fatal. Therefore, continuous subcutaneous (SC) infusion delivered just beneath the skin is the preferred type of delivery.
- Worsening of PAH symptoms. Do not stop taking or greatly reduce your Remodulin dose without consulting your doctor.
- Low blood pressure (symptomatic hypotension). If you have low blood pressure or are taking drugs that lower your blood pressure, the risk of low blood pressure is increased.
- Bleeding problems. Remodulin may increase the risk of bleeding in people who take blood thinners (anticoagulants).
What are the possible side effects of Remodulin?
- In clinical studies of SC infusion of Remodulin, most people experienced infusion site pain and infusion site reaction (redness, swelling, and rash). These symptoms were sometimes severe and sometimes required treatment with narcotics or discontinuation of Remodulin.
- IV infusion of Remodulin delivered through an external pump has been associated with the risk of blood stream infections, arm swelling, tingling sensations, bruising, and pain.
- The most common side effects seen with either SC or IV Remodulin were headache, diarrhea, nausea, rash, jaw pain, widening of the blood vessels (vasodilatation), and swelling from fluid retention (edema). These are not all the possible side effects of Remodulin. Call your doctor for medical advice about side effects.
You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.
Please see accompanying Full Prescribing Information for Remodulin.
For additional information, visit http://www.remodulin.com or call Customer Service at 1-877-UNITHER (1-877-864-8437).
This information is provided for an informational purpose and is not intended as treatment advice. Patients should consult a healthcare professional for treatment advice.